Bone health evidence brief
Vitamin K2 refers to menaquinone forms involved in vitamin K-dependent proteins. It is usually used for bone health, calcium handling, and cardiovascular calcification claims.
Vitamin K2 has plausible bone and calcification roles, but supplementation claims are strongest in deficiency-risk or osteoporosis contexts, not general longevity use.
RCT meta-analyses report bone-marker and some fracture signals, while cardiovascular calcification trials remain inconsistent.
Studies use different menaquinone forms and doses; food intake, vitamin D, calcium, anticoagulant use, and baseline risk all change the interpretation.
People using warfarin or other vitamin K-sensitive anticoagulants should not change vitamin K intake without clinical supervision.
Source Drawer
The score reflects evidence that the supplement does its stated job. Some jobs are direct, such as strength, endurance, or recovery; others are indirect, such as sleep, mood, appetite, or health support. A real effect can still receive a cautious practical rating when dose, safety, product quality, or audience fit remain uncertain.
Send the disputed claim, source link, and why it changes the practical verdict. Corrections that materially affect the claim, dose, caveat, or rating are prioritized.
Report a source or rating issue